NCT05098327 2023-08-15
Pioglitazone and Insulin Resistance in ADT
State University of New York at Buffalo
Phase 3 Withdrawn
Clinical Trials
10 trialsNCT04995978 2023-06-23
Insulin Resistance and Androgen Deprivation Therapy
St. Louis University
Phase 2 Withdrawn
NCT04658849 2023-05-15
Insulin Resistance Following ADT for Prostate CA
St. Louis University
Phase EARLY_PHASE1 Withdrawn
NCT01006395 2019-07-05
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Austin Health
Phase 2/3 Completed
NCT03447028 2018-02-27
TyG-PCa
Recep Tayyip Erdogan University Training and Research Hospital
Completed
NCT01227213 2015-10-30
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Radboud University Medical Center
Completed
NCT01300104 2015-02-19
Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer
Danish Cancer Society
Phase NA Completed
NCT01584960 2013-12-02
The Effect of Endurance Training in Patients With Prostate Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT00455624 2013-07-11
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
Massachusetts General Hospital
Completed
NCT00456144 2013-07-11
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer
Massachusetts General Hospital
Completed